Recombinant Vibrio vulnificus Glycine dehydrogenase [decarboxylating] (gcvP), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
gcvP; VVA0691; Glycine dehydrogenase; decarboxylating; EC 1.4.4.2; Glycine cleavage system P-protein; Glycine decarboxylase; Glycine dehydrogenase; aminomethyl-transferring)
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Vibrio vulnificus (strain YJ016)
Target Names
gcvP
Uniprot No.

Target Background

Function

The glycine cleavage system catalyzes glycine degradation. The P protein binds glycine's alpha-amino group via its pyridoxal phosphate cofactor; CO2 is released, and the remaining methylamine moiety is transferred to the lipoamide cofactor of the H protein.

Database Links

KEGG: vvy:VVA0691

Protein Families
GcvP family

Q&A

What is Glycine dehydrogenase (gcvP) and what role does it play in bacterial metabolism?

Glycine dehydrogenase (gcvP), also known as P-protein, is a pyridoxal 5′-phosphate (PLP)-dependent enzyme that initiates the glycine cleavage system (GCS) reaction cycle. This enzyme system is essential for glycine degradation and one-carbon metabolism in bacteria, archaea, and all eukaryotes . In bacterial metabolism, gcvP serves several critical functions:

  • Glycine decarboxylation: It cleaves glycine into CO₂ and an aminomethyl intermediate, which is then transferred to the lipoyl prosthetic group of the H-protein.

  • One-carbon metabolism: The GCS contributes to the synthesis of nucleotides and certain amino acids through the generation of one-carbon units .

  • Redox homeostasis: Recent research indicates that gcvP activity is regulated by cellular redox status, with disulfide formation driving conformational changes that can inactivate the enzyme under certain conditions .

The GCS reaction cycle involves four proteins working in concert: the PLP-dependent P-protein (gcvP), the tetrahydrofolate (THF)-dependent T-protein (aminomethyltransferase), the NAD⁺-dependent L-protein (dihydrolipoamide dehydrogenase), and the small lipoylated H-protein that interacts successively with the other three components .

How is the gcvP gene organized and regulated in bacterial systems?

The gcvP gene typically exists as part of a conserved operon structure in bacterial systems. Based on studies in related organisms, we can infer the following about V. vulnificus gcvP regulation:

The gene is likely part of the gcvTHP operon, which shows significant conservation across bacterial species. This operon encodes three of the four proteins of the glycine cleavage system: the T-protein (aminomethyltransferase), H-protein (hydrogen carrier protein), and P-protein (glycine dehydrogenase).

Regulation of the gcvP gene involves several key mechanisms:

  • Glycine induction: The operon is typically inducible by glycine, with studies in related bacterial systems showing up to 7-fold increases in transcriptional activity in the presence of glycine.

  • Redox regulation: The activity of the P-protein is regulated by cellular redox homeostasis. Disulfide formation can drive conformational changes that inactivate the enzyme, providing a mechanism for the cell to control glycine decarboxylase activity based on redox conditions .

  • Species conservation: Amino acid sequences of gcvP are generally conserved across bacterial species, with identity ranges of 40-95% reported between various bacterial homologs. This conservation suggests essential roles in bacterial metabolism.

What are the key structural and functional domains of bacterial gcvP proteins?

Bacterial gcvP proteins, including that of V. vulnificus, possess several key structural and functional domains that are essential for their enzymatic activity:

  • PLP-binding domain: As a pyridoxal phosphate (PLP)-dependent enzyme, gcvP contains a critical PLP-binding site. The cofactor forms a Schiff base with a lysine residue in the active site, which is essential for catalysis .

  • Homodimeric structure: Glycine decarboxylase P-protein typically exists as a homodimer, with the crystal structure revealing important insights into its molecular organization .

  • Redox-sensitive elements: The protein contains disulfide bonds that can form under oxidizing conditions, driving conformational changes that regulate enzyme activity .

  • H-protein interaction interface: The P-protein must interact with the H-protein to transfer the aminomethyl group generated from glycine decarboxylation to the lipoyl prosthetic group of the H-protein .

The functional activity of gcvP involves a transaldimination reaction where glycine reacts with the PLP on the P-protein to form an external aldimine. This complex subsequently loses the carboxyl group as CO₂ and donates the remaining aminomethylene moiety to the oxidized lipoamide arm of H-protein .

How does redox regulation affect bacterial gcvP activity and what methodologies can be used to study this phenomenon?

Redox regulation represents a significant control mechanism for bacterial gcvP activity, including that of V. vulnificus. Research indicates that disulfide formation drives conformational changes that can inactivate the cyanobacterial P-protein, and this likely applies to other bacterial systems as well .

Methodological approaches to study this redox regulation include:

  • Site-directed mutagenesis: By systematically replacing cysteine residues involved in disulfide formation, researchers can evaluate the impact on enzyme activity under varying redox conditions. This approach helps identify specific residues critical for redox sensitivity.

  • Enzymatic assays under controlled redox conditions: Activity assays performed in buffers with varying ratios of oxidized and reduced glutathione or dithiothreitol can reveal the redox potential at which the enzyme transitions between active and inactive states.

  • Crystal structure determination: Structural studies at different redox states provide visual evidence of conformational changes. For example, crystallizing the enzyme under oxidizing and reducing conditions can reveal structural rearrangements associated with disulfide formation .

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This technique can detect changes in protein dynamics and solvent accessibility associated with redox-dependent conformational changes without requiring crystallization.

For V. vulnificus gcvP specifically, researchers should consider comparative analyses with better-characterized homologs, as direct experimental data may be limited. The molecular model for redox regulation provided by cyanobacterial P-protein studies offers a valuable template for investigating similar mechanisms in V. vulnificus .

What role might V. vulnificus gcvP play in bacterial stress response and adaptation?

The role of gcvP in bacterial stress response and adaptation likely extends beyond its primary metabolic function. Based on studies of related systems, V. vulnificus gcvP may contribute to stress adaptation through several mechanisms:

  • One-carbon metabolism regulation: During stress conditions, changes in gcvP activity could redirect metabolic flux through one-carbon metabolic pathways, affecting nucleotide synthesis, amino acid metabolism, and methylation reactions critical for stress adaptation .

  • Redox homeostasis contribution: The redox-sensitive nature of gcvP suggests it may function as a redox sensor, helping bacteria respond to oxidative stress conditions by adjusting metabolic pathways .

  • Potential role in biofilm formation: Studies in Vibrio species have shown that mutations affecting c-di-GMP signaling pathways impact biofilm formation . While not directly linked to gcvP in the available research, the metabolic changes resulting from altered gcvP activity could influence biofilm development, a common bacterial stress response.

  • Virulence regulation: In related organisms, alterations in one-carbon metabolism impact pathogenicity. For example, in Sinorhizobium, gcvP inactivation affects host interaction specificity. Similar mechanisms might exist in V. vulnificus, where gcvP activity could influence virulence factor expression.

Methodologically, researchers can investigate these potential roles through:

  • Transcriptomic and proteomic analyses comparing wild-type and gcvP mutant strains under various stress conditions.

  • Phenotypic assays examining biofilm formation, virulence factor production, and stress survival in strains with altered gcvP expression.

  • Metabolomic analyses to track changes in one-carbon metabolites and related pathways during stress adaptation.

The link between one-carbon metabolism and bacterial adaptation is further supported by research showing that V. cholerae exposed to environmental stressors developed numerous genetic changes that affected metabolic regulation and stress responses .

How do the kinetic properties of V. vulnificus gcvP compare with those of other bacterial species?

Comparing the kinetic properties of V. vulnificus gcvP with those of other bacterial species provides valuable insights into species-specific adaptations and evolutionary conservation. While direct kinetic data for V. vulnificus gcvP is limited in the provided search results, we can make informed comparisons based on studies of homologous enzymes:

Methodologically, researchers can address these comparative questions through:

  • Recombinant expression and purification of V. vulnificus gcvP alongside homologs from other species.

  • Standardized enzymatic assays under identical conditions to generate comparable kinetic parameters.

  • Inhibitor screening panels to identify species-specific sensitivity patterns.

  • Structural modeling and docking studies to predict differences in substrate binding and catalysis based on sequence variations.

What expression systems and purification strategies are optimal for producing active recombinant V. vulnificus gcvP?

Successful expression and purification of active recombinant V. vulnificus gcvP requires careful consideration of expression systems and purification strategies. Based on approaches used with similar enzymes, the following methodological recommendations can be made:

  • Expression systems:

    • E. coli BL21(DE3) or its derivatives represent the first-choice expression host due to their high expression levels and compatibility with T7-based expression vectors.

    • For challenging cases, consider specialized strains such as Rosetta (for rare codon optimization) or Origami (for enhanced disulfide bond formation).

    • Expression vectors with tightly regulated inducible promoters (T7, tac, or araBAD) allow control over expression timing and intensity.

    • Fusion tags (His6, GST, or MBP) can improve solubility and facilitate purification, with the His6-tag being particularly advantageous for PLP-dependent enzymes.

  • Expression conditions:

    • Lower temperatures (16-25°C) after induction often improve protein folding and solubility.

    • Supplementation with pyridoxal phosphate (50-100 μM) during expression can enhance cofactor incorporation.

    • IPTG concentrations between 0.1-0.5 mM typically provide optimal induction without overwhelming cellular machinery.

    • Extended expression times (16-24 hours) at lower temperatures may yield higher amounts of active protein.

  • Purification strategies:

    • Multi-step purification combining affinity chromatography (IMAC for His-tagged constructs) followed by size exclusion chromatography to ensure homogeneity.

    • Buffer optimization is critical, with typical buffers containing:

      • 50 mM Tris-HCl or phosphate buffer (pH 7.5-8.0)

      • 100-300 mM NaCl

      • 5-10% glycerol for stability

      • 1-5 mM DTT or 2-mercaptoethanol to maintain reduced state

      • 20-50 μM PLP to ensure cofactor saturation

  • Activity preservation:

    • Inclusion of PLP in all purification buffers prevents cofactor loss.

    • Addition of glycerol (10-20%) in storage buffers enhances enzyme stability.

    • Flash-freezing in liquid nitrogen and storage at -80°C with minimal freeze-thaw cycles.

When optimizing these conditions, researchers should perform small-scale expression trials varying temperature, induction conditions, and buffer compositions to identify parameters that yield the highest activity of the purified enzyme.

What assays are most reliable for measuring V. vulnificus gcvP activity and kinetic parameters?

Reliable measurement of V. vulnificus gcvP activity requires carefully designed assays that account for the enzyme's cofactor requirements and reaction mechanism. The following methodological approaches are recommended:

  • Decarboxylation assays:

    • Radiometric assay using 14C-labeled glycine with measurement of released 14CO2 trapped on alkali-soaked filters.

    • This approach directly quantifies the primary catalytic activity (decarboxylation) and provides high sensitivity.

    • Typical reaction conditions: 50 mM potassium phosphate buffer (pH 7.5), 0.1-1 mM [1-14C]glycine, 1-5 μg purified gcvP, and 50 μM PLP at 30-37°C.

  • Coupled spectrophotometric assays:

    • Assays that couple the gcvP reaction to the complete glycine cleavage system (requiring T-protein, H-protein, and L-protein) with measurement of NAD+ reduction at 340 nm.

    • This approach mimics the physiological reaction but requires purification of additional proteins.

    • GCV activity can be measured as nmol/min/mg protein, with values ranging from 0.4 to 1.2 nmol/min/mg protein reported in related systems.

  • H-protein interaction assays:

    • Assays measuring the transfer of the aminomethyl group to lipoylated H-protein.

    • Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) to determine binding kinetics between gcvP and H-protein.

  • Redox sensitivity assessment:

    • Activity measurements under controlled redox potentials using defined ratios of oxidized/reduced glutathione.

    • This approach reveals the redox regulation profile specific to V. vulnificus gcvP.

For kinetic parameter determination:

  • Vary glycine concentration (typically 0.05-10 mM) while maintaining other components at saturating levels.

  • Plot reaction rates versus substrate concentration and fit to appropriate enzyme kinetics models (Michaelis-Menten, Hill, etc.).

  • Determine Km, Vmax, and catalytic efficiency (kcat/Km) values.

  • For inhibition studies, include varying concentrations of potential inhibitors and determine inhibition constants (Ki) and mechanisms.

When reporting activity data, it is essential to clearly state:

  • Specific activity in standardized units (μmol/min/mg protein)

  • Precise reaction conditions (pH, temperature, buffer composition)

  • Cofactor concentrations and state of the H-protein (lipoylated vs. non-lipoylated)

  • Enzyme concentration and purity assessment method

How can researchers effectively study the interaction between recombinant V. vulnificus gcvP and other components of the glycine cleavage system?

Studying the interactions between recombinant V. vulnificus gcvP and other components of the glycine cleavage system (GCS) requires specialized methodological approaches that address both physical interactions and functional cooperation. The following strategies are recommended:

When interpreting interaction data, researchers should consider the potential impact of redox conditions, as disulfide formation has been shown to drive conformational changes that can inactivate the cyanobacterial P-protein , and similar mechanisms may exist in V. vulnificus gcvP.

How can researchers address common challenges in recombinant V. vulnificus gcvP expression and activity measurement?

Researchers working with recombinant V. vulnificus gcvP frequently encounter specific challenges that require systematic troubleshooting approaches. The following methodological solutions address common issues:

  • Addressing low expression yields:

    • Optimize codon usage for the expression host by synthesizing a codon-optimized gene sequence.

    • Test multiple expression strains (BL21, Rosetta, Arctic Express) to identify the optimal host.

    • Evaluate different fusion tags (His, MBP, SUMO) that can enhance solubility.

    • Consider autoinduction media instead of IPTG induction for gentler expression kinetics.

    • If toxicity is suspected, use tightly controlled expression systems with lower basal expression.

  • Resolving protein insolubility:

    • Lower induction temperature (16-20°C) and extend expression time (16-24 hours).

    • Co-express with molecular chaperones (GroEL/GroES, DnaK/DnaJ/GrpE).

    • Include stabilizing additives in lysis buffer (10% glycerol, 0.1% Triton X-100, 1 mM PLP).

    • If necessary, develop refolding protocols from inclusion bodies using gradual dialysis methods.

  • Addressing poor enzyme activity:

    • Ensure complete incorporation of the PLP cofactor by including excess PLP (50-100 μM) during purification and storage.

    • Verify the redox state of the enzyme, as disulfide formation can inactivate gcvP . Include reducing agents (1-5 mM DTT) in buffers if appropriate.

    • Check for inhibitory contaminants in reagents, particularly in glycine stocks.

    • Optimize buffer conditions systematically (pH range 6.5-8.5, salt concentration 50-500 mM).

    • Ensure the H-protein is properly lipoylated, as studies show minimal activity with non-lipoylated H-protein.

  • Troubleshooting inconsistent assay results:

    • Implement rigorous quality control for all protein components, including SDS-PAGE, size exclusion chromatography, and mass spectrometry.

    • For each new protein preparation, determine specific activity under standardized conditions.

    • Include positive controls (commercial enzymes if available) and internal standards.

    • Measure enzyme stability over time under assay conditions to account for potential inactivation.

    • Control for batch-to-batch variation in reagents, particularly PLP and H-protein preparations.

  • Data analysis considerations:

    • Apply appropriate statistical methods for comparing activity data between different preparations or conditions.

    • Use non-linear regression for accurate determination of kinetic parameters.

    • Consider enzyme-specific factors in data interpretation, such as potential cooperativity or substrate inhibition.

    • When comparing V. vulnificus gcvP with homologs from other species, normalize data appropriately to account for differences in assay conditions.

By implementing these methodological approaches, researchers can overcome common challenges and generate reliable, reproducible data on V. vulnificus gcvP function and interactions.

How can researchers resolve contradictory findings when studying the structure-function relationships of V. vulnificus gcvP?

Contradictory findings in structure-function studies of V. vulnificus gcvP can arise from methodological differences, environmental variables, or inherent properties of the enzyme. The following approaches can help researchers systematically address and resolve such discrepancies:

  • Critical evaluation of experimental conditions:

    • Map exactly how experimental conditions differ between contradictory studies, focusing on:

      • Buffer composition (pH, ionic strength, reducing agents)

      • Temperature and reaction time

      • Enzyme concentration and purity

      • Presence of stabilizing additives or contaminants

    • Reproduce both contradictory conditions side-by-side to directly compare results.

    • Systematically vary parameters to identify which specific factor(s) cause the discrepancy.

  • Protein state analysis:

    • Assess the oligomeric state of the enzyme using size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS).

    • Verify cofactor binding status using spectroscopic methods (UV-visible spectroscopy for PLP binding).

    • Evaluate redox state through methods like Ellman's assay for free thiols, as disulfide formation has been shown to impact gcvP activity .

    • Employ circular dichroism (CD) spectroscopy to confirm secondary structure integrity.

    • These analyses can reveal if contradictory findings result from studying the enzyme in different conformational or redox states.

  • Domain-specific functional analysis:

    • Create domain truncation or swapping constructs similar to approaches used with VvGBE (Vibrio vulnificus Glycogen Branching Enzyme), where domain-truncated and domain-swapped mutants revealed the crucial role of specific domains in determining function .

    • Test these constructs under the contradictory conditions to determine if specific domains respond differently to experimental variables.

    • This approach can pinpoint which structural elements are responsible for divergent behaviors.

  • Computational integration of contradictory data:

    • Develop structural models that can accommodate seemingly contradictory findings.

    • Use molecular dynamics simulations to explore how different experimental conditions might drive conformational changes.

    • Apply ensemble modeling approaches that consider multiple protein states rather than a single static structure.

  • Reconciliation strategies for data analysis:

    • Consider that apparent contradictions may represent different physiological states of the enzyme.

    • Implement statistical approaches like Bayesian inference to integrate diverse datasets.

    • Develop mechanistic models that can explain condition-dependent behavior.

When reporting resolved contradictions, researchers should clearly document the methodological differences that explain the discrepancies and propose a unified model that accommodates the full range of observations. This approach not only resolves immediate contradictions but also builds a more comprehensive understanding of V. vulnificus gcvP structure-function relationships.

What emerging technologies could advance our understanding of V. vulnificus gcvP function and regulation?

Several cutting-edge technologies offer promising avenues for deepening our understanding of V. vulnificus gcvP function and regulation. Researchers should consider these emerging approaches to break new ground in this field:

  • Cryo-electron microscopy (cryo-EM) advancements:

    • Single-particle cryo-EM can now achieve near-atomic resolution of dynamic enzyme complexes.

    • Time-resolved cryo-EM could potentially capture the gcvP enzyme at different stages of its catalytic cycle.

    • These techniques could reveal how V. vulnificus gcvP interacts with H-protein and undergoes conformational changes during catalysis, building upon our current understanding of glycine decarboxylase structure .

  • Integrative structural biology approaches:

    • Combining X-ray crystallography, cryo-EM, small-angle X-ray scattering (SAXS), and computational modeling.

    • These complementary methods can generate comprehensive structural models of gcvP in different functional states and in complex with other GCS components.

    • Such integrated approaches have proven valuable for understanding complex enzyme systems similar to gcvP.

  • Advanced genetic techniques:

    • CRISPR-Cas9 genome editing in V. vulnificus to create precise mutations in the native gcvP gene.

    • CRISPRi for controlled knockdown of gcvP expression to study its physiological roles.

    • These approaches enable investigating gcvP function in its natural cellular context, potentially revealing new roles in bacterial stress adaptation similar to those observed in V. cholerae studies .

  • Single-molecule enzymology:

    • Fluorescence resonance energy transfer (FRET) with labeled gcvP and H-protein to monitor interactions at the single-molecule level.

    • Optical tweezers or magnetic tweezers to study force-dependent conformational changes.

    • These techniques could reveal heterogeneity in enzyme behavior and transient interactions not detectable in bulk assays.

  • Systems biology integration:

    • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics to understand how gcvP functions within larger metabolic networks.

    • Flux analysis using stable isotope labeling to trace carbon flow through gcvP-dependent pathways.

    • These integrated approaches could connect gcvP activity to broader cellular processes, similar to how glycine metabolism has been linked to stress adaptation in other Vibrio species .

  • Artificial intelligence for protein engineering:

    • Machine learning algorithms trained on protein sequence-function relationships to predict the effects of mutations.

    • AI-guided directed evolution to develop gcvP variants with enhanced stability or altered substrate specificity.

    • These computational approaches could accelerate the engineering of gcvP for biotechnological applications.

By adopting these emerging technologies, researchers can address fundamental questions about V. vulnificus gcvP that have remained challenging with conventional approaches, potentially leading to breakthroughs in understanding bacterial metabolism and developing new antimicrobial strategies targeting this enzyme.

How might V. vulnificus gcvP research contribute to broader understanding of bacterial metabolic adaptation and pathogenicity?

Research on V. vulnificus gcvP has significant potential to contribute to our broader understanding of bacterial metabolism, adaptation, and pathogenicity through several key pathways:

  • One-carbon metabolism and stress adaptation:

    • V. vulnificus gcvP research can elucidate how glycine metabolism and one-carbon flux contribute to bacterial stress responses.

    • Similar to observations in other bacteria where long-term exposure to environmental stressors resulted in genetic changes affecting metabolism , studies of gcvP may reveal how one-carbon metabolism adjusts during adaptation to environmental challenges.

    • This research could establish mechanistic links between central metabolism and stress survival, potentially applicable across diverse bacterial species.

  • Redox signaling networks:

    • The redox regulation of gcvP through disulfide formation represents a model for how metabolic enzymes can function as redox sensors.

    • Comparative studies of V. vulnificus gcvP with homologs from other species could reveal species-specific adaptations in redox sensing mechanisms.

    • This work may uncover broader principles of how bacteria integrate metabolic activity with redox homeostasis during infection and environmental stress.

  • Metabolic underpinnings of virulence:

    • Investigation of how gcvP activity influences virulence factor production in V. vulnificus could reveal novel connections between metabolism and pathogenicity.

    • Drawing parallels to studies in related species where inactivation of gcvP affected host interaction specificity, V. vulnificus research might identify metabolic checkpoints that regulate virulence.

    • These insights could inform the development of anti-virulence strategies targeting metabolic pathways rather than growth.

  • Comparative evolutionary insights:

    • Detailed characterization of V. vulnificus gcvP structure, function, and regulation enables evolutionary comparisons with homologs from diverse bacteria.

    • Such analyses could reveal how variations in gcvP have contributed to niche adaptation across bacterial species.

    • This evolutionary perspective might identify conserved vulnerability points for broad-spectrum antimicrobial development.

  • Biofilm metabolism:

    • Studies linking gcvP activity to biofilm formation could build upon observations that evolved V. cholerae variants exhibited increased biofilm formation after stress adaptation .

    • Understanding how one-carbon metabolism contributes to the biofilm lifestyle may reveal new approaches to disrupt bacterial communities.

    • This research direction connects fundamental metabolism to a clinically relevant bacterial behavior.

  • Therapeutic target validation:

    • Characterization of V. vulnificus gcvP structure and function could validate it as a potential antimicrobial target.

    • Similar to work on GLDC (glycine decarboxylase) in human disease , bacterial gcvP research might reveal therapeutic strategies for targeting this enzyme.

    • Inhibitor development guided by structural insights could lead to new antibacterial compounds with novel mechanisms of action.

By pursuing these research directions, work on V. vulnificus gcvP will contribute valuable insights extending well beyond a single enzyme or species, potentially transforming our understanding of bacterial metabolism and its role in adaptation and pathogenesis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.